PharmaLundensis AB announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced operating loss was SEK 694,356 compared to SEK 1.473 million a year ago. Net loss was SEK 796,219 compared to SEK 1.539 million a year ago.